-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
-
Summary
-
ACADIA PHARMACEUTICALS INC quarterly Deferred Income Tax Liabilities, Net history and change rate from Q4 2019 to Q4 2024.
- ACADIA PHARMACEUTICALS INC Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2024 was $11.4M, a 7.83% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)